BROMANTANE
A synthetic adaptogen and actoprotector that enhances dopamine synthesis and physical endurance without typical stimulant dependence.
Animal studies show bromantane improves physical work capacity by 1.3-1.6 times compared to amphetamine at optimal doses, with effects lasting at least 24 hours. EEG studies in rats reveal a two-phase stimulant profile with peaks at 2-3 and 6-7 hours, persisting up to 8 hours. A two-month oral administration study found no development of tolerance or drug dependence, though sex-dependent psychodysleptic effects were observed at toxic doses (600 mg/kg). Thermoprotective effects during overheating have been documented, alongside alterations in protein metabolism and antioxidant systems. However, the evidence base is predominantly Russian-language animal research with very limited human clinical trial data.